Free Trial

Bellevue Healthcare (LON:BBH) Stock Crosses Below 50 Day Moving Average - Should You Sell?

Bellevue Healthcare logo with Financial Services background

Bellevue Healthcare (LON:BBH - Get Free Report)'s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 136.92 ($1.77) and traded as low as GBX 123.23 ($1.59). Bellevue Healthcare shares last traded at GBX 123.80 ($1.60), with a volume of 913,061 shares trading hands.

Bellevue Healthcare Trading Down 0.7 %

The company has a market cap of £302.09 million and a price-to-earnings ratio of -18.64. The stock's 50-day moving average is GBX 136.02 and its 200-day moving average is GBX 140.51.

Bellevue Healthcare (LON:BBH - Get Free Report) last announced its quarterly earnings data on Tuesday, March 18th. The company reported GBX 0.03 ($0.00) earnings per share for the quarter. Bellevue Healthcare had a net margin of 169.10% and a negative return on equity of 4.48%.

Bellevue Healthcare Dividend Announcement

The company also recently announced a dividend, which will be paid on Friday, May 30th. Investors of record on Thursday, May 1st will be issued a GBX 2.52 ($0.03) dividend. This represents a dividend yield of 2.01%. The ex-dividend date of this dividend is Thursday, May 1st. Bellevue Healthcare's dividend payout ratio is currently -91.26%.

Bellevue Healthcare Company Profile

(Get Free Report)

Bellevue Healthcare Trust plc is a high conviction, long-only investment trust invested in listed or quoted global healthcare equities. It is unconstrained and able to invest regardless of market cap, sub sector or region, and the portfolio is concentrated with a maximum of 35 holdings. The target total dividend in the first financial period is 3.5 pence per ordinary share (to be paid mostly out of capital) and in subsequent financial years will be set at 3.5 per cent.

Read More

Should You Invest $1,000 in Bellevue Healthcare Right Now?

Before you consider Bellevue Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bellevue Healthcare wasn't on the list.

While Bellevue Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines